WestEnd Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.96K | Buy |
25
+3
| +14% | +$235 | ﹤0.01% | 150 |
|
|
2025
Q1 | $1.6K | Buy |
22
+14
| +175% | +$1.02K | ﹤0.01% | 169 |
|
|
2024
Q4 | $592 | Buy |
8
+1
| +14% | +$74 | ﹤0.01% | 160 |
|
|
2024
Q3 | $462 | Sell |
7
-1
| -13% | -$66 | ﹤0.01% | 181 |
|
|
2024
Q2 | $739 | Sell |
8
-2
| -20% | -$185 | ﹤0.01% | 136 |
|
|
2024
Q1 | $956 | Buy |
10
+1
| +11% | +$96 | ﹤0.01% | 117 |
|
|
2023
Q4 | $686 | Buy |
9
+1
| +13% | +$76 | ﹤0.01% | 133 |
|
|
2023
Q3 | $554 | Buy |
+8
| New | +$554 | ﹤0.01% | 143 |
|
|
2023
Q2 | – | Hold |
0
| – | -$662 | – | 128 |
|
|
2023
Q1 | – | Sell |
-7
| Closed | -$522 | – | 133 |
|
|
2022
Q4 | $522 | Sell |
7
-1
| -13% | -$75 | ﹤0.01% | 143 |
|
|
2022
Q3 | $1K | Hold |
8
| – | – | ﹤0.01% | 108 |
|
|
2022
Q2 | $760 | Buy |
+8
| New | +$760 | ﹤0.01% | 121 |
|
|
2022
Q1 | – | Sell |
-5
| Closed | -$647 | – | 126 |
|
|
2021
Q4 | $647 | Buy |
+5
| New | +$647 | ﹤0.01% | 141 |
|
|
2021
Q3 | – | Hold |
0
| – | -$517K | – | 137 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 139 |
|